Literature DB >> 33637019

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.

Xianwen Ren1, Lei Zhang1,2, Yuanyuan Zhang1, Ziyi Li1, Nathan Siemers3, Zemin Zhang1.   

Abstract

Understanding tumor immune microenvironments is critical for identifying immune modifiers of cancer progression and developing cancer immunotherapies. Recent applications of single-cell RNA sequencing (scRNA-seq) in dissecting tumor microenvironments have brought important insights into the biology of tumor-infiltrating immune cells, including their heterogeneity, dynamics, and potential roles in both disease progression and response to immune checkpoint inhibitors and other immunotherapies. This review focuses on the advances in knowledge of tumor immune microenvironments acquired from scRNA-seq studies across multiple types of human tumors, with a particular emphasis on the study of phenotypic plasticity and lineage dynamics of immune cells in the tumor environment. We also discuss several imminent questions emerging from scRNA-seq observations and their potential solutions on the horizon.

Entities:  

Keywords:  immunotherapy; single-cell RNA-seq; single-cell transcriptomics; tumor immunity; tumor microenvironment

Year:  2021        PMID: 33637019     DOI: 10.1146/annurev-immunol-110519-071134

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  22 in total

Review 1.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

2.  Global-Scale Profiling of Differential Expressed Lysine-Lactylated Proteins in the Cerebral Endothelium of Cerebral Ischemia-Reperfusion Injury Rats.

Authors:  Yuan Yao; Rengui Bade; Guotao Li; Aoqi Zhang; Haile Zhao; Lifei Fan; Runxiu Zhu; Jun Yuan
Journal:  Cell Mol Neurobiol       Date:  2022-08-27       Impact factor: 4.231

3.  Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.

Authors:  Wanjia Tian; Junying Zhou; Mengyu Chen; Luojie Qiu; Yike Li; Weiwei Zhang; Ruixia Guo; Ningjing Lei; Lei Chang
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

4.  Downregulated Copper Homeostasis-Related Gene FOXO1 as a Novel Indicator for the Prognosis and Immune Response of Breast Cancer.

Authors:  Rong Zeng; Bi Peng; Emin Peng
Journal:  J Immunol Res       Date:  2022-06-28       Impact factor: 4.493

5.  A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer.

Authors:  Yi Yang; Hong-Li Liu; Yi-Jing Liu
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

6.  Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck.

Authors:  Yuying Zhu; Shikang Zheng; Xingyou Zhai; Cheng Wang; Aijun Liu; Jun Ju; Xin Peng; Liwei Chen; Yongxia Zhang; Nan Ren; Yingli Xie; Junda Fan; Kai Zhao; Mingbo Liu
Journal:  J Immunol Res       Date:  2022-04-18       Impact factor: 4.493

7.  CancerSCEM: a database of single-cell expression map across various human cancers.

Authors:  Jingyao Zeng; Yadong Zhang; Yunfei Shang; Jialin Mai; Shuo Shi; Mingming Lu; Congfan Bu; Zhewen Zhang; Zaichao Zhang; Yang Li; Zhenglin Du; Jingfa Xiao
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

8.  The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma.

Authors:  Likui Fang; Guocan Yu; Wenfeng Yu; Gang Chen; Bo Ye
Journal:  PeerJ       Date:  2021-10-04       Impact factor: 2.984

9.  Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.

Authors:  Longchao Liu; Jiahui Chen; Hongyi Zhang; Jianfeng Ye; Casey Moore; Changzheng Lu; Yan Fang; Yang-Xin Fu; Bo Li
Journal:  Nat Cancer       Date:  2022-04-07

Review 10.  Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Xin Luo; Jing Xu; Jianhua Yu; Ping Yi
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.